<DOC>
	<DOCNO>NCT03104556</DOCNO>
	<brief_summary>The MitraClip-procedure offer interventional treatment high risk patient severe symptomatic mitral regurgitation . The number new cerebral ischemic lesion without clinical manifestation high . The aim study determine frequency cerebral embolisms cerebral lesion MitraClip-procedure use transcranial doppler ultrasound magnetic resonance imaging .</brief_summary>
	<brief_title>Silent sTROke duriNG MitraClip Implantation</brief_title>
	<detailed_description>Mitral regurgitation second common manifestation valvular heart disease adult . Surgical reconstruction consider treatment choice . For patient surgical risk high operation refuse . For Patients MitraClip system ( Abbott Vascular , Menlo Park , CA , USA ) offer much less invasive treatment option . Occurrence stroke transient ischemic attack ( TIA ) one potential complication procedure . 1 % patient acute stroke . The number new ischemic lesion without clinical manifestation much high ( 85 % ) . The impact lesion global cognitive function unclear . The aim study determine frequency cerebral embolisms relate predefined procedural interval postprocedural cerebral lesion use Transcranial Doppler ultrasound magnetic resonance imaging . Furthermore want study correlation cerebral embolism see high intensity signal transcranial duplex ultrasound cerebral lesion see cMRT . The result build basis study want reduce amount cerebral lesion .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Patients undergoing MitraClipprocedure due mitral regurgitation study period Written consent Procedure recommend CardioThoracic Surgery Conference Patients able give consent Patients &lt; 18 year Participation another interventional Trial Pregnant lactate female Contraindication MRI</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>